vs
HARVARD BIOSCIENCE INC（HBIO）与REDWOOD TRUST INC（RWT）财务数据对比。点击上方公司名可切换其他公司
REDWOOD TRUST INC的季度营收约是HARVARD BIOSCIENCE INC的1.1倍（$25.9M vs $23.7M），REDWOOD TRUST INC净利率更高（77.2% vs -12.0%，领先89.2%），HARVARD BIOSCIENCE INC同比增速更快（-3.3% vs -6.1%），过去两年HARVARD BIOSCIENCE INC的营收复合增速更高（-1.6% vs -41.0%）
哈佛生物科学是一家全球生命科学设备开发商、制造商与销售商，其产品主要用于支撑科研开发与药物研发工作，目前该公司在纳斯达克上市，股票交易代码为HBIO。
Redwood Trust Inc是总部位于美国的专业房地产投资信托公司，主营住宅与商业抵押贷款、抵押贷款支持证券及房地产信贷类资产的投资管理，核心业务覆盖住宅抵押贷款发放、商业地产信贷和投资服务，客户以机构投资者和房地产市场参与者为主。
HBIO vs RWT — 直观对比
营收规模更大
RWT
是对方的1.1倍
$23.7M
营收增速更快
HBIO
高出2.7%
-6.1%
净利率更高
RWT
高出89.2%
-12.0%
两年增速更快
HBIO
近两年复合增速
-41.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $23.7M | $25.9M |
| 净利润 | $-2.8M | $20.0M |
| 毛利率 | 59.7% | — |
| 营业利润率 | 7.2% | — |
| 净利率 | -12.0% | 77.2% |
| 营收同比 | -3.3% | -6.1% |
| 净利润同比 | -15916.7% | 402.6% |
| 每股收益（稀释后） | $-0.06 | $0.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HBIORWT
| Q4 25 | $23.7M | $25.9M | ||
| Q3 25 | $20.6M | $15.0M | ||
| Q2 25 | $20.4M | $13.8M | ||
| Q1 25 | $21.8M | $27.9M | ||
| Q4 24 | $24.6M | $27.6M | ||
| Q3 24 | $22.0M | $25.5M | ||
| Q2 24 | $23.1M | $67.4M | ||
| Q1 24 | $24.5M | $74.5M |
净利润HBIORWT
| Q4 25 | $-2.8M | $20.0M | ||
| Q3 25 | $-1.2M | $-7.7M | ||
| Q2 25 | $-2.3M | $-98.5M | ||
| Q1 25 | $-50.3M | $16.1M | ||
| Q4 24 | $18.0K | $-6.6M | ||
| Q3 24 | $-4.8M | $14.8M | ||
| Q2 24 | $-2.9M | $15.5M | ||
| Q1 24 | $-4.7M | $30.3M |
毛利率HBIORWT
| Q4 25 | 59.7% | — | ||
| Q3 25 | 58.4% | — | ||
| Q2 25 | 56.4% | — | ||
| Q1 25 | 56.0% | — | ||
| Q4 24 | 57.1% | — | ||
| Q3 24 | 58.1% | — | ||
| Q2 24 | 57.2% | — | ||
| Q1 24 | 60.3% | — |
营业利润率HBIORWT
| Q4 25 | 7.2% | — | ||
| Q3 25 | 1.0% | -9.0% | ||
| Q2 25 | -4.0% | -679.0% | ||
| Q1 25 | -228.1% | 80.2% | ||
| Q4 24 | 0.0% | -1.3% | ||
| Q3 24 | -8.5% | 86.1% | ||
| Q2 24 | -9.0% | 30.3% | ||
| Q1 24 | -9.3% | 41.3% |
净利率HBIORWT
| Q4 25 | -12.0% | 77.2% | ||
| Q3 25 | -6.0% | -51.4% | ||
| Q2 25 | -11.2% | -712.0% | ||
| Q1 25 | -231.2% | 57.8% | ||
| Q4 24 | 0.1% | -24.0% | ||
| Q3 24 | -21.9% | 58.1% | ||
| Q2 24 | -12.7% | 23.0% | ||
| Q1 24 | -19.1% | 40.6% |
每股收益（稀释后）HBIORWT
| Q4 25 | $-0.06 | $0.11 | ||
| Q3 25 | $-0.03 | $-0.08 | ||
| Q2 25 | $-0.05 | $-0.76 | ||
| Q1 25 | $-1.14 | $0.10 | ||
| Q4 24 | $0.01 | $-0.08 | ||
| Q3 24 | $-0.11 | $0.09 | ||
| Q2 24 | $-0.07 | $0.10 | ||
| Q1 24 | $-0.11 | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $8.6M | $255.7M |
| 总债务越低越好 | $35.9M | — |
| 股东权益账面价值 | $13.7M | $982.6M |
| 总资产 | $80.1M | $23.7B |
| 负债/权益比越低杠杆越低 | 2.61× | — |
8季度趋势，按日历期对齐
现金及短期投资HBIORWT
| Q4 25 | $8.6M | $255.7M | ||
| Q3 25 | $6.8M | $226.3M | ||
| Q2 25 | $7.4M | $302.0M | ||
| Q1 25 | $5.5M | $259.9M | ||
| Q4 24 | $4.1M | $245.2M | ||
| Q3 24 | $4.6M | $253.7M | ||
| Q2 24 | $4.0M | $275.6M | ||
| Q1 24 | $4.3M | $275.4M |
总债务HBIORWT
| Q4 25 | $35.9M | — | ||
| Q3 25 | $34.0M | — | ||
| Q2 25 | $34.9M | — | ||
| Q1 25 | $36.4M | — | ||
| Q4 24 | $37.0M | — | ||
| Q3 24 | $34.9M | — | ||
| Q2 24 | $35.7M | — | ||
| Q1 24 | $35.6M | $1.7B |
股东权益HBIORWT
| Q4 25 | $13.7M | $982.6M | ||
| Q3 25 | $14.1M | $999.0M | ||
| Q2 25 | $15.7M | $1.1B | ||
| Q1 25 | $14.8M | $1.2B | ||
| Q4 24 | $63.3M | $1.2B | ||
| Q3 24 | $65.3M | $1.2B | ||
| Q2 24 | $67.2M | $1.2B | ||
| Q1 24 | $68.8M | $1.2B |
总资产HBIORWT
| Q4 25 | $80.1M | $23.7B | ||
| Q3 25 | $78.0M | $22.6B | ||
| Q2 25 | $80.1M | $21.3B | ||
| Q1 25 | $79.8M | $19.9B | ||
| Q4 24 | $126.6M | $18.3B | ||
| Q3 24 | $131.2M | $18.4B | ||
| Q2 24 | $128.9M | $16.5B | ||
| Q1 24 | $133.2M | $15.1B |
负债/权益比HBIORWT
| Q4 25 | 2.61× | — | ||
| Q3 25 | 2.41× | — | ||
| Q2 25 | 2.22× | — | ||
| Q1 25 | 2.45× | — | ||
| Q4 24 | 0.58× | — | ||
| Q3 24 | 0.53× | — | ||
| Q2 24 | 0.53× | — | ||
| Q1 24 | 0.52× | 1.39× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-96.0K | $-10.1B |
| 自由现金流经营现金流 - 资本支出 | $-545.0K | — |
| 自由现金流率自由现金流/营收 | -2.3% | — |
| 资本支出强度资本支出/营收 | 1.9% | — |
| 现金转化率经营现金流/净利润 | — | -504.15× |
| 过去12个月自由现金流最近4个季度 | $5.5M | — |
8季度趋势，按日历期对齐
经营现金流HBIORWT
| Q4 25 | $-96.0K | $-10.1B | ||
| Q3 25 | $1.1M | $-2.7B | ||
| Q2 25 | $2.8M | $-2.1B | ||
| Q1 25 | $3.0M | $-2.0B | ||
| Q4 24 | $1.7M | $-5.9B | ||
| Q3 24 | $-842.0K | $-2.1B | ||
| Q2 24 | $-846.0K | $-2.0B | ||
| Q1 24 | $1.4M | $-954.2M |
自由现金流HBIORWT
| Q4 25 | $-545.0K | — | ||
| Q3 25 | $877.0K | — | ||
| Q2 25 | $2.7M | — | ||
| Q1 25 | $2.5M | — | ||
| Q4 24 | $1.4M | — | ||
| Q3 24 | $-1.7M | — | ||
| Q2 24 | $-1.7M | — | ||
| Q1 24 | $758.0K | — |
自由现金流率HBIORWT
| Q4 25 | -2.3% | — | ||
| Q3 25 | 4.3% | — | ||
| Q2 25 | 13.0% | — | ||
| Q1 25 | 11.4% | — | ||
| Q4 24 | 5.8% | — | ||
| Q3 24 | -7.8% | — | ||
| Q2 24 | -7.2% | — | ||
| Q1 24 | 3.1% | — |
资本支出强度HBIORWT
| Q4 25 | 1.9% | — | ||
| Q3 25 | 1.0% | — | ||
| Q2 25 | 0.4% | — | ||
| Q1 25 | 2.4% | — | ||
| Q4 24 | 1.2% | — | ||
| Q3 24 | 4.0% | — | ||
| Q2 24 | 3.5% | — | ||
| Q1 24 | 2.6% | — |
现金转化率HBIORWT
| Q4 25 | — | -504.15× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -120.92× | ||
| Q4 24 | 95.83× | — | ||
| Q3 24 | — | -140.86× | ||
| Q2 24 | — | -126.56× | ||
| Q1 24 | — | -31.53× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
HBIO
| Instruments Equipment Software And Accessories | $21.6M | 91% |
| Service Maintenance And Warranty Contracts | $2.1M | 9% |
RWT
暂无分部数据
